Economic Advantages of Domestic Production of Biosimilar Medicines in Iran
Background: Biosimilars can be considered generic versions of branded biologic medicines. Substituting branded biologic medicines with biosimilars is important to reduce medication costs. In addition to reducing drug costs, the domestic production of biosimilars can provide many other economic benef...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Shahid Sadoughi University of Medical Sciences
2023-09-01
|
Series: | Rāhburdhā-yi Mudīriyyat dar Niẓām-i Salāmat |
Subjects: | |
Online Access: | http://mshsj.ssu.ac.ir/article-1-653-en.pdf |